Shopping Cart
- Remove All
- Your shopping cart is currently empty
Balicatib (AAE581) is a potent and selective inhibitor of cathepsin K, used in trials studying the treatment of osteoporosis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | 33 € | In Stock | |
5 mg | 53 € | In Stock | |
10 mg | 95 € | In Stock | |
25 mg | 223 € | In Stock | |
50 mg | 418 € | In Stock | |
100 mg | 604 € | In Stock | |
500 mg | 1.263 € | In Stock | |
1 mL x 10 mM (in DMSO) | 58 € | In Stock |
Description | Balicatib (AAE581) is a potent and selective inhibitor of cathepsin K, used in trials studying the treatment of osteoporosis. |
Kinase Assay | Cell-free kinase activity assays: Glutathione-S-transferase (GST)-tagged JAK kinase domains expressed in insect cells are purified before use in a peptide substrate phosphorylation assay. Assays are carried out in 384-well optiplates using an Alphascreen Protein Tyrosine Kinase P100 detection kit and a PerkinElmer Fusion Alpha instrument. |
Alias | AAE581 |
Molecular Weight | 411.54 |
Formula | C23H33N5O2 |
Cas No. | 354813-19-7 |
Smiles | CCCN1CCN(CC1)c1ccc(cc1)C(=O)NC1(CCCCC1)C(=O)NCC#N |
Relative Density. | 1.19 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (121.49 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.